Oral supplementation of A. muciniphila restored the efficacy of PD-1 blockade in mice in a white blood cell-dependent manner by increasing the recruitment of CCR9+ CXCR3+ CD4+ T lymphocytes to the mouse tumor bed after FMT using nonresponder feces (229). Here, CD4 is linked to neoplasm.